Merck & Co., Inc.
MRK
$114.71
-$1.17-1.01%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -5.07% | 9.30% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -5.07% | 9.30% | |||
| Cost of Revenue | 14.69% | 10.41% | |||
| Gross Profit | -10.54% | 9.00% | |||
| SG&A Expenses | 10.16% | -0.60% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.80% | 3.48% | |||
| Operating Income | -23.75% | 19.01% | |||
| Income Before Tax | -49.30% | 34.93% | |||
| Income Tax Expenses | -52.19% | 67.78% | |||
| Earnings from Continuing Operations | -48.82% | 30.69% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 150.00% | -100.00% | |||
| Net Income | -48.78% | 30.68% | |||
| EBIT | -23.75% | 19.01% | |||
| EBITDA | -16.62% | 16.60% | |||
| EPS Basic | -48.64% | 31.46% | |||
| Normalized Basic EPS | -26.16% | 19.79% | |||
| EPS Diluted | -48.64% | 31.74% | |||
| Normalized Diluted EPS | -26.07% | 19.78% | |||
| Average Basic Shares Outstanding | -0.28% | -0.60% | |||
| Average Diluted Shares Outstanding | -0.40% | -0.60% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.94% | -0.25% | |||